191 related articles for article (PubMed ID: 24927150)
21. Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.
Jiang J; Gui F; He Z; Li L; Li Y; Li S; Wu X; Deng Z; Sun X; Huang X; Huang W; Han S; Zhang T; Wang Z; Jiao B; Song S; Wang H; Chen L; Zhou D; Liu Q; Ren R; Zhang J; Deng X
Cancer Res; 2017 Jan; 77(1):175-186. PubMed ID: 27758886
[TBL] [Abstract][Full Text] [Related]
22. Istaroxime Inhibits Motility and Down-Regulates Orai1 Expression, SOCE and FAK Phosphorylation in Prostate Cancer Cells.
Stagno MJ; Zacharopoulou N; Bochem J; Tsapara A; Pelzl L; Al-Maghout T; Kallergi G; Alkahtani S; Alevizopoulos K; Dimas K; Calogeropoulou T; Warmann SW; Lang F; Schmid E; Stournaras C
Cell Physiol Biochem; 2017; 42(4):1366-1376. PubMed ID: 28704809
[TBL] [Abstract][Full Text] [Related]
23. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC
Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190
[TBL] [Abstract][Full Text] [Related]
24. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
25. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
26. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells.
Park EH; Kim S; Jo JY; Kim SJ; Hwang Y; Kim JM; Song SY; Lee DK; Koh SS
Carcinogenesis; 2013 Mar; 34(3):694-702. PubMed ID: 23222813
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression.
Kim ES; Kim SY; Koh M; Lee HM; Kim K; Jung J; Kim HS; Moon WK; Hwang S; Moon A
Oncogene; 2018 Jan; 37(1):28-38. PubMed ID: 28846105
[TBL] [Abstract][Full Text] [Related]
28. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
Schlienger S; Ramirez RA; Claing A
Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
[TBL] [Abstract][Full Text] [Related]
29. Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion.
Foudah AI; Jain S; Busnena BA; El Sayed KA
ChemMedChem; 2013 Mar; 8(3):497-510. PubMed ID: 23404739
[TBL] [Abstract][Full Text] [Related]
30. Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.
Shah GV; Muralidharan A; Thomas S; Gokulgandhi M; Mudit M; Khanfar M; El Sayed K
Mol Cancer Ther; 2009 Mar; 8(3):509-20. PubMed ID: 19276166
[TBL] [Abstract][Full Text] [Related]
31. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
32. Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy.
Williams KE; Bundred NJ; Landberg G; Clarke RB; Farnie G
Stem Cells; 2015 Feb; 33(2):327-41. PubMed ID: 25187396
[TBL] [Abstract][Full Text] [Related]
33. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
[TBL] [Abstract][Full Text] [Related]
35. The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse.
Huang SM; Hsu PC; Chen MY; Li WS; More SV; Lu KT; Wang YC
Int J Cancer; 2012 Aug; 131(3):722-32. PubMed ID: 22015944
[TBL] [Abstract][Full Text] [Related]
36. Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.
Anuj ; Arivazhagan L; Venkatraman G; Rayala SK
Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670568
[TBL] [Abstract][Full Text] [Related]
37. Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer.
Kandil SB; Jones SR; Smith S; Hiscox SE; Westwell AD
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751931
[TBL] [Abstract][Full Text] [Related]
38. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
39. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530.
Green TP; Fennell M; Whittaker R; Curwen J; Jacobs V; Allen J; Logie A; Hargreaves J; Hickinson DM; Wilkinson RW; Elvin P; Boyer B; Carragher N; Plé PA; Bermingham A; Holdgate GA; Ward WH; Hennequin LF; Davies BR; Costello GF
Mol Oncol; 2009 Jun; 3(3):248-61. PubMed ID: 19393585
[TBL] [Abstract][Full Text] [Related]
40. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]